Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Feasibility of a Digital Therapeutic for Adults With Posttraumatic Stress Disorder (PTSD)

NCT: NCT06868446 · COMPLETED

NCT IDNCT06868446
StatusCOMPLETED
Start Date2025-06-30
Completion2025-11-21
SponsorOui Therapeutics, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

This study is exploring the efficacy of a digital therapeutic app in reducing symptoms of posttraumatic stress disorder (PTSD) in adults.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑